THERAPIST BRIEFINGS NEWS - THE LATEST RESEARCH IN BEHAVIORAL HEALTH
1001 articles available (Viewing 1 - 15)
CDC: Health Insurance Among Young Increased After ACA Since the Affordable Care Act extended dependent health coverage to young adults up to 26 years old, the percentage of this age group with private health insurance has increased and the percentage with gaps in insurance coverage has decreased, according to a December data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.
No Serious Heart Risks With Smoking Cessation Therapies Three licensed smoking cessation therapies -- nicotine replacement therapy, bupropion, and varenicline -- seem not to be associated with an increased risk of serious cardiovascular disease events, according to a meta-analysis published online Dec. 9 in Circulation.
Outdoor Recess Ups Quantity, Intensity of Physical Activity Outdoor recess is associated with increased quantity and intensity of physical activity compared with indoor recess settings, according to a study published Nov. 21 in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease.
Stage III/IV Melanoma Patients at Risk for New Primaries Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas, although the incidence rates are lower than those observed in studies of dabrafenib and vemurafenib, according to research published online Dec. 2 in the Journal of Clinical Oncology.
Global Burden of Dementia Shifting to Poorer Countries In the coming decades, the global burden of dementia will shift even further from richer countries to poorer countries, especially rapidly developing middle-income countries, according to an Alzheimer's Disease International policy brief. The brief is being published ahead of the G8 Dementia Summit, which will be held in London on Dec. 11.
FDA Approves New Drug for Peyronie's Disease Xiaflex (collagenase clostridium histolyticum) has been approved by the U.S. Food and Drug Administration to treat Peyronie's disease. The drug -- first sanctioned three years ago to treat Dupuytren's contracture -- is the first medication to be approved by the agency to treat Peyronie's.
Satisfaction With Weight Linked to Happy Relationships Women who are happy with their weight are more likely to be happy in their relationship, have greater self-esteem, and be less self-conscious about their body, according to a study presented at the annual meeting of the British Psychological Society's Division of Clinical Psychology, held from Dec. 4 to 6 in York, U.K.